Akzo Nobel Confirms Approach to ICI With Possible Cash Offer
Akzo Nobel believes that ICI would represent a
highly attractive addition to its focused coatings and chemicals business
following the announced sale of Organon BioSciences N.V. earlier this year.
Akzo Nobel will continue to evaluate all strategic opportunities, including
ICI, based on a disciplined and value-driven approach to earnings and returns
over cost of capital.
There can be no certainty that any further proposal
will be made to the board of ICI or that any offer or transaction will result.